Bioton S.a. Return on Equity

Bioton S.a. (BIO.WA) currently reports a ROE of -1.44%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Bioton S.a.'s ROE history and peer comparisons.

Bioton S.a.'s ROE of -1.44% is higher than the Healthcare sector average of -75.84%. That is roughly 98.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Bioton S.a.'s current -1.44% should be judged against Healthcare norms (sector average: -75.84%) and against BIO.WA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -1.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Bioton S.a., and consider following BIO.WA for alerts when major investors trade the stock.

Bioton S.a. is classified in the Healthcare sector. On ROE, it currently shows -1.44% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIO.WA with unrelated industries.